Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe revision label changes from v3.5.3 to v3.5.4, indicating a platform/template update. This metadata update does not appear to alter the displayed study details or content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version change without altering the study details shown.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision notes updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check77 days agoChange DetectedSite revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This update appears to be a metadata/version change and does not modify the study data, criteria, or results.SummaryDifference0.1%

- Check99 days agoChange DetectedMetadata and timestamp updates were applied to the study page. Core trial details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.